ASX - Delayed Quote AUD

Visioneering Technologies, Inc. (VTI.AX)

Compare
0.0650
-0.0040
(-5.80%)
At close: January 17 at 3:59:16 PM GMT+11

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Dr. Juan Carlos Aragon CEO & Executive Director 644.11k -- --
Dr. Kuang-Mon Tuan FAAO, Ph.D. Chief Medical Officer 531.39k -- --
Dr. Richard A. Griffin OD Founder & Medical Adviser -- -- --

Visioneering Technologies, Inc.

30 Mansell Court
Suite 215
Alpharetta, GA 30076
United States
844 884 5367 https://www.vtivision.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Corporate Governance

Visioneering Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 26, 2025 at 9:17 PM UTC - February 5, 2025 at 9:17 PM UTC

Visioneering Technologies, Inc. Earnings Date

Recent Events

Related Tickers